The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Factors of Inpatients with Severe Atopic Dermatitis Treated in a Traditional Korean Medicine Hospital

한방병원에서 입원치료를 시행한 중증 아토피피부염 환자의 예후지표 탐색

  • Kwak, Jae-Young (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Kim, Min-Hee (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Kang, Min-Seo (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Park, So-Young (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Choi, In-Hwa (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong)
  • 곽재영 (강동경희대학교병원 한방안이비인후피부과) ;
  • 김민희 (강동경희대학교병원 한방안이비인후피부과) ;
  • 강민서 (강동경희대학교병원 한방안이비인후피부과) ;
  • 박소영 (강동경희대학교병원 한방안이비인후피부과) ;
  • 최인화 (강동경희대학교병원 한방안이비인후피부과)
  • Received : 2018.10.09
  • Accepted : 2018.11.05
  • Published : 2018.11.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : This study was aimed to find significant prognostic factor of inpatients with severe atopic dermatitis (AD) who treated in a Traditional Korean Medicine (TKM) hospital. Methods : A retrospective review of medical records of 39 patients with severe AD who hospitalized for more than 7days was performed. All patients were treated with acupuncture, herbal decoction and herbal wet wrap dressing. Therapeutic effect was assessed by difference of objective SCORing of Atopic Dermatitis index (${\Delta}OSI$) at admission and at discharge. Patients were divided into two groups: improvement group (${\Delta}OSI{\leq}5$) and no-improvement group (${\Delta}OSI>5$), and clinical characteristics, severity, infectious complication, serum total IgE, eosinophil counts, adherence and concomitant treatment were investigated. Results : There were 7 cases in no-improvement group. There was no significant difference in OSI or infectious complication between the two groups. Also, there was no significant difference in total serum IgE and eosinophil counts, which are known to be related to severity of AD. However, the proportion of adherence group was significantly lower in no-improvement group than improvement group. Conclusions : This study suggest that treatment adherence is a significant prognostic factor for treatment outcome in inpatients with severe atopic dermatitis. If the adherence to treatment is improved, the therapeutic effect of hospitalization would increase in spite of severe AD or infectious complication.

Keywords

References

  1. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-60. https://doi.org/10.1016/S0140-6736(03)12193-9
  2. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. Journal of Investigative Dermatology. 2011;131(1):67-73 https://doi.org/10.1038/jid.2010.251
  3. Kim BK, Kim JY, Kang MK, Yang MS, Park HW, Min KU, et al. Allergies are still on the rise? A 6-year nationwide populationbased study in Korea. Allergology International. 2016;65(2):186-91. https://doi.org/10.1016/j.alit.2015.11.002
  4. Kwak YH, Kim YJ. Health-related Quality of Life and Mental Health of Adults With Atopic Dermatitis. Archives of psychiatric nursing. 2017;31(5):516-21. https://doi.org/10.1016/j.apnu.2017.06.001
  5. Kim DH, Li K, Seong SJ, Jo SJ, Wim HW, Kim CM, et al. Quality of life and disease severity are correlated in patients with atopic dermatitis. Journal of Korean medical science. 2012;27(11):1327-32. https://doi.org/10.3346/jkms.2012.27.11.1327
  6. Megna M, Napolitano M, Patruno C, Villani A, Balato A, Monfrecola G, et al. Systemic treatment of adult atopic dermatitis: a review. Dermatology and therapy. 2017; 7(1):1-23. https://doi.org/10.1007/s13555-016-0170-1
  7. Mooney E, Rademaker M, Dailey R, Daniel BS, Drummond C, Fischer G, et al. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australasian Journal of Dermatology. 2015;56(4):241-51. https://doi.org/10.1111/ajd.12313
  8. Junior A, Reis N dos, Costa IMC. The use of alternative or complementary medicine for children with atopic dermatitis. Anais brasileiros de dermatologia. 2011;86(1):167-8. https://doi.org/10.1590/S0365-05962011000100033
  9. Gu SX, Zhang AL, Coyle ME, Chen D, Xue CC. Chinese herbal medicine for atopic eczema: an overview of clinical evidence. Journal of Dermatological Treatment. 2017;28(3):246-50. https://doi.org/10.1080/09546634.2016.1214673
  10. Thandar Y, Gray A, Botha J, Mosam A. Topical herbal medicines for atopic eczema: a systematic review of randomized controlled trials. British Journal of Dermatology. 2017;176(2):330-43. https://doi.org/10.1111/bjd.14840
  11. Tan HY, Lenon GB, Zhang AL, Xue CC. Efficacy of acupuncture in the management of atopic dermatitis: a systematic review. Clinical and experimental dermatology. 2015;40(7):711-6. https://doi.org/10.1111/ced.12732
  12. Yun YH, Lee SD, Kim SH, Choi IH. Inpatient treatment for severe atopic dermatitis in a traditional Korean medicine hospital: introduction and retrospective chart review. Complementary therapies in medicine. 2013;21(3):200-6. https://doi.org/10.1016/j.ctim.2012.12.002
  13. Yun YH, Son JW, Kim KS, Jang BH, Choi IH, Ko SG. Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis: a retrospective chart review. Integrative medicine research. 2017;6(1):19-25. https://doi.org/10.1016/j.imr.2017.01.002
  14. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh)(suppl). 1980;92:44-7.
  15. Kunz B, Oranje A, Labreze L, Stalder J-F, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-9.
  16. Ference JD, Last AR. Choosing topical corticosteroids. American family physician. 2009;79(2).
  17. Kim HS, Jo SH. Treatment for atopic dermatitis. Journal of the Korean Medical Association. 2014;57(3):226-33. https://doi.org/10.5124/jkma.2014.57.3.226
  18. Ayyalaraju RS, Finlay AY, Dykes PJ, Trent JT, Kirsner RS, Kerdel FA. Hospitalization for severe skin disease improves quality of life in the United Kingdom and the United States: a compara-tive study. Journal of the American Academy of Dermatology. 2003;49(2):249-54. https://doi.org/10.1067/S0190-9622(03)00897-1
  19. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. American journal of clinical dermatology. 2006;7(4):231-6. https://doi.org/10.2165/00128071-200607040-00004
  20. Tan X, Feldman SR, Chang JW, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert opinion on drug delivery. 2012;9(10):1263-71. https://doi.org/10.1517/17425247.2012.711756